Trials / Completed
CompletedNCT00434486
Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606
An Open-Label, Randomized, 2-Period Crossover Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606 Administered Orally to Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SKI-606 |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2007-02-13
- Last updated
- 2007-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00434486. Inclusion in this directory is not an endorsement.